26 results on '"Gérard, Alexandre O."'
Search Results
2. The Neuropsychiatric Safety Profile of Lasmiditan: A Comparative Disproportionality Analysis with Triptans
3. CAR-T Cells and the Kidney: Insights from the WHO Safety Database
4. Cardiac and metabolic safety profile of antipsychotics in youths: A WHO safety database analysis
5. Drug-induced cardiac toxicity and adverse drug reactions, a narrative review
6. Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence
7. A HPLC-DAD method to facilitate large-scale therapeutic drug monitoring of dalbavancin
8. Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database
9. An artificial intelligence algorithm for co‐clustering to help in pharmacovigilance before and during the COVID‐19 pandemic.
10. Drug-related catatonia in youths: real-world insights from the WHO Safety Database
11. Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis
12. Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth?
13. New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review
14. Medications as a Trigger of Sleep-Related Eating Disorder: A Disproportionality Analysis
15. Drug-Induced Tubulointerstitial Nephritis: Insights From the World Health Organization Safety Database
16. Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review
17. COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety Database
18. Real‐World Data on the Risk of Ventricular Arrhythmias with Sulfonamides
19. Case Report: Severe Hypercalcemia Following Vitamin D Intoxication in an Infant, the Underestimated Danger of Dietary Supplements
20. Risk factors associated with immune checkpoint inhibitor–induced acute kidney injury compared with other immune-related adverse events: a case–control study.
21. Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database
22. Association Between Maintenance Immunosuppressive Regimens and COVID-19 Mortality in Kidney Transplant Recipients
23. Immune checkpoint inhibitors-induced nephropathy: a French national survey.
24. Empagliflozin in Heart Failure.
25. Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence.
26. Empagliflozin in Heart Failure.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.